Risk factor
Strong & resilient to price shocks
Profitability factor
Strong margins and returns
About
Straumann Holding AG is a global leader in providing advanced solutions for tooth replacement and orthodontic treatment. The company actively researches, develops, manufactures, and distributes a comprehensive range of dental products and services designed for tooth correction, restoration, replacement, and the prevention of tooth loss. Its extensive portfolio includes various dental implant systems (such as titanium, titanium alloy, ceramic, and mini implants), specialized surgical instruments, sophisticated CAD/CAM prosthetics, and the Clear Correct orthodontic aligners. Straumann also supplies vital biomaterials, including bone substitutes, membranes, and biologics, alongside cutting-edge digital tools like intraoral scanners, 3D printers, and milling machines for dental professionals and laboratories. Additionally, the company offers educational and training services to its customers. Straumann serves a diverse clientele, encompassing general dentists, specialists, dental technicians, laboratories, and institutional clients such as distributors, hospitals, and universities, reaching approximately 100 countries through its broad network of subsidiaries and partners. Established in 1954, Straumann Holding AG is headquartered in Basel, Switzerland.
Company Valuation
Considering past and projected metrics, the stock is distinctly 'expensive' compared to its peers. In particular, the stock is overpriced on P/E, 'expensive' on EV/EBITDA
Target Price
The average target price of STMN.SW is 109 and suggests 1.99% upside potential. Usually, this means a HOLD recommendation among investment firms. This neutral recommendat